Skip to main content
MLSS
NYSE Industrial Applications And Services

Milestone Scientific Q3 Loss Narrows but Going-Concern Doubt Persists; NYSE Listing Deadline April 8, 2027

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$0.316
Mkt Cap
$26.287M
52W Low
$0.218
52W High
$0.58
52W Position info
45% above low
Off High info
46% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

MLSS sits 45% above its 52-week low of $0.218.

Summary

Milestone Scientific narrowed its Q3 2026 net loss to $747,545 from $1,153,959, but with only about $1.3 million of cash it still carries a going-concern warning and must fix its NYSE American equity deficiency by April 8, 2027.


Key Events · Earnings and Guidance · MLSS

  • Q3 Loss Narrows on Cost Cuts

    Net loss was $747,545 for the three months ended September 30, 2026 versus $1,153,959 a year earlier. For the nine months, the net loss fell to $2,467,985 from $4,631,655 as operating expenses dropped about 21% to $7.5 million.

  • Going-Concern Doubt Not Alleviated

    Cash was about $1.3 million with working capital of about $3.5 million and an accumulated deficit of about $136.0 million. Management states that substantial doubt about the ability to continue as a going concern within one year has not been alleviated.

  • NYSE American Equity Deficiency

    The company must regain compliance with NYSE American's $4 million and $6 million stockholders' equity standards by April 8, 2027. Reported equity was about $3.7 million at September 30, 2026.

  • Convertible Notes Fully Converted

    Holders converted the remaining $466,000 of principal plus $22,000 of accrued interest on August 19, 2026, leaving no convertible notes payable outstanding at quarter end.


Analysis · MLSS · Industrial Applications And Services

Operationally the quarter improved: net loss fell to $747,545 from $1,153,959 a year earlier, and nine-month operating expenses dropped about 21%. The core problem, however, is unchanged. The company ended September with roughly $1.3 million of cash against a $136.0 million accumulated deficit, and management explicitly says substantial doubt about continuing as a going concern has not been alleviated. Layered on top is an NYSE American deficiency: with stockholders' equity of about $3.7 million at September 30, 2026, the company must regain compliance with the $4 million and $6 million continued-listing standards by April 8, 2027 or face delisting. The April 2026 private placement ($2.15 million gross, $1.80 million cash) and the August conversion of the remaining convertible notes bought time and cleaned up the balance sheet, but another raise is likely needed inside the assessment period.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MLSS was trading at $0.32 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $26.3M. The 52-week trading range was $0.22 to $0.58. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MLSS - Latest Insights